Cellectar Biosciences (CLRB) Share-based Compensation (2010 - 2025)
Cellectar Biosciences (CLRB) posted Share-based Compensation of $567,788 for Q4 2025, down 61.8% from $1.49 million a year earlier and unchanged from the prior quarter.
Cellectar Biosciences (CLRB) Share-based Compensation (2010 - 2025) Analysis & Trends
For FY2025, Cellectar Biosciences' Share-based Compensation came in at $2.26 million, down 47.0% from FY2024.
- Annual Share-based Compensation shows a five-year compound annual growth rate of 37.1% (FY2020 to FY2025).
- In prior years, Cellectar Biosciences' Share-based Compensation was $4.27 million in FY2024 (+77.3%), $2.41 million in FY2023 (+65.9%), $1.45 million in FY2022 (+29.2%) and $1.12 million in FY2021 (+140.4%).
- Quarterly Share-based Compensation has run from a low of $124,564 in Q1 2021 to a high of $1.53 million in Q3 2024 over five years.
- On a year-over-year basis, Share-based Compensation has declined in each of the last three quarters, with growth averaging 27.1% over the last eight quarters.
- The strongest year-over-year quarter for Share-based Compensation in the past five years was Q3 2021, with growth of 262.2%; the weakest was Q3 2025, with a decline of 63.0%.
- According to Business Quant data, Share-based Compensation for the three prior quarters was $567,788 (Q3 2025), $565,391 (Q2 2025) and $562,737 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.98 Bn | 1,134.57 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 643.66 Bn | 563.53 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 500.95 Bn | 474.06 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 358.08 Bn | 312.45 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 301.84 Bn | 265.83 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 267.25 Bn | 240.94 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.42 Bn | 196.81 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 193.09 Bn | 167.28 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 171.63 Bn | 118.27 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Cellectar Biosciences | 15.04 Mn | -55.74 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 567,788.00 |
| Sep 30, 2025 | 567,788.00 |
| Jun 30, 2025 | 565,391.00 |
| Mar 31, 2025 | 562,737.00 |
| Dec 31, 2024 | 1.49 Mn |
| Sep 30, 2024 | 1.53 Mn |
| Jun 30, 2024 | 799,250.00 |
| Mar 31, 2024 | 454,363.00 |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 497,878.00 |
| Jun 30, 2023 | 419,757.00 |
| Mar 31, 2023 | 408,206.00 |
| Dec 31, 2022 | 361,447.00 |
| Sep 30, 2022 | 367,759.00 |
| Jun 30, 2022 | 419,953.00 |
| Mar 31, 2022 | 303,805.00 |
| Dec 31, 2021 | 377,848.00 |
| Sep 30, 2021 | 421,161.00 |
| Jun 30, 2021 | 200,617.00 |
| Mar 31, 2021 | 124,564.00 |
Cellectar Biosciences Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CLRB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();